This is a non-core endpoint: only basic statistics are computed.
Hypergammalglobulinemia, unspecified
DOID EFO MESH SNOMED Endpoint Browser
D3_HYPERGAMMAGLONAS
immune system disease: A disorder resulting from an abnormality in the immune system.
Endpoint definition
↥429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
2 out of 7 registries used, show all original rules.
30
Check minimum number of events None
30
Include endpoints None
30
Remove individuals based on genotype QC
30
Control definitions
Extra metadata
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to Hypergammalglobulinemia, unspecified based on the number of shared cases.
Broader endpoints:
- Other disorders involving the immune mechanism, not elsewhere classified
- Certain disorders involving the immune mechanism
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Narrower endpoints:
None
Summary Statistics
↥Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 30 | 12 | 18 |
Unadjusted prevalence (%) | 0.01 | 0.01 | 0.01 |
Mean age at first event (years) | 59.87 | 52.82 | 64.57 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: D3_HYPERGAMMAGLONAS – Hypergammalglobulinemia, unspecified
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Hypergammalglobulinemia, unspecified
↥Endpoint not on priority list, no data to show.